Elizabeth A. Pilling

Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial

James Griffiths, P A Jenkins, Monika Vargová et al. · The Lancet · 2019 · 167 citations · Full text

Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies

Eva Germovsek, Irja Lutsar, Karin Kipper et al. · Journal of Antimicrobial Chemotherapy · 2018 · 74 citations · Full text

Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors

Emerson A. Lim, Johanna C. Bendell, Gerald S. Falchook et al. · Clinical Cancer Research · 2022 · 67 citations · Full text

Abstract CT007: PETRA: First in class, first in human trial of the next generation PARP1-selective inhibitor AZD5305 in patients (pts) with BRCA1/2, PALB2 or RAD51C/D mutations

Timothy A. Yap, Seock‐Ah Im, Alison M. Schram et al. · Cancer Research · 2022 · 66 citations

Human Trial, Prior Parpi, Rad51c/d Mutations +15

Antimicrobial-impregnated central venous catheters for prevention of neonatal bloodstream infection (PREVAIL): an open-label, parallel-group, pragmatic, randomised controlled trial

Ruth Gilbert, Michaela Brown, Naomi Rainford et al. · The Lancet Child & Adolescent Health · 2019 · 57 citations · Full text